Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Aug 15, 2020; 12(8): 833-849
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.833
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.833
Histotype | Subtype | Frequency, % |
Ductal adenocarcinoma | NOS | 85% |
Carcinoma undifferentiated | 1%-7% | |
Adenosquamous carcinoma | 1%-4% | |
Undifferentiated carcinoma with osteoclast-like giant cell | < 1% | |
Colloid carcinoma | 1%-3% | |
Poorly cohesive carcinoma | Extremely rare | |
Signet-ring cell carcinoma | Extremely rare | |
Medullary carcinoma NOS | Extremely rare | |
Hepatoid carcinoma | Extremely rare | |
Large cell with rhabdoid phenotype | Extremely rare | |
Acinar cell carcinoma | NOS | < 2% |
Acinar cell cystadenocarcinoma | Extremely rare | |
Mixed acinar-neuroendocrine carcinoma | Extremely rare | |
Mixed acinar-endocrine-ductal carcinoma | Extremely rare | |
Mixed acinar -ductal carcinoma | Extremely rare | |
Pancreatoblastoma | Extremely rare | |
Solid pseudopapillary neoplasm | NOS | 3% |
With high-grade carcinoma | Extremely rare |
- Citation: Niger M, Prisciandaro M, Antista M, Monica MAT, Cattaneo L, Prinzi N, Manglaviti S, Nichetti F, Brambilla M, Torchio M, Corti F, Pusceddu S, Coppa J, Mazzaferro V, de Braud F, Di Bartolomeo M. One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches. World J Gastrointest Oncol 2020; 12(8): 833-849
- URL: https://www.wjgnet.com/1948-5204/full/v12/i8/833.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i8.833